Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Vanderbilt-led Team Discovers New Genetic Disease and Defines Underlying Mechanism


 
Cartilage cells in the zebrafish model of the disease CATIFA (right) have reduced volumes and irregular shapes compared to healthy cartilage cells (left) because of a defect in collagen secretion. Image courtesy of Ela Knapik, MD.

Studies that started in zebrafish have now pointed to a role for collagen secretion in a wide variety of clinical symptoms -- and in a newly identified genetic syndrome.


Ela Knapik, MD

Ela Knapik, MD, associate professor of Medicine at Vanderbilt University Medical Center, and her colleagues discovered the syndrome caused by mutation of a single gene and named it CATIFA, an acronym for its core symptoms: cleft palate, cataracts, tooth abnormality, intellectual disability, facial dysmorphism and ADHD.

The study, reported in Nature Medicine, combined three sources of information: a zebrafish model, a pediatric genetic disease and a database of electronic health records linked to a DNA biobank.

"Each of these three data sources has its own advantages and shortcomings for disease discovery," said Knapik, who is also associate professor of Cell and Developmental Biology at Vanderbilt University. "I thought, why don't we use them concurrently."

Knapik and her team were exploring the function of a gene called ric1 in zebrafish. They knew that mutation of ric1 disrupted collagen secretion and caused craniofacial and other skeletal defects in fish.

They learned that another group of investigators had reported a mutation in the RIC1 gene (the human version of the zebrafish ric1 gene) in multiple children from a single family who had pediatric cataracts. Knapik's team evaluated the zebrafish for cataracts, but didn't find any.

The story might have ended there, but Knapik was intrigued. Did the children have other symptoms that hadn't been characterized because their most pressing problem was cataracts? What might those symptoms be?

To uncover additional symptoms, Knapik and her colleagues in the Vanderbilt Genetics Institute turned to BioVU, Vanderbilt's DNA biobank and database of de-identified electronic health records.

Eric Gamazon, PhD, research instructor in Medicine, and Nancy Cox, PhD, Mary Phillips Edmonds Gray Professor of Genetics and director of the Vanderbilt Genetics Institute, had previously developed a computational method, called PrediXcan, to correlate genetically regulated gene expression with patient phenome -- the clinical characteristics included in the electronic health record. When applied to BioVU, the method generates a list of clinical characteristics linked to reduced expression of a specific gene.

The list they generated for reduced RIC1 expression matched characteristics Knapik and her team observed in the fish, she said. "I knew at that moment that we needed more information about the patients with RIC1 mutation and pediatric cataracts."

The team in Saudi Arabia that had reported the patients with RIC1 mutation agreed to reevaluate those patients for the BioVU-derived list of symptoms. Knapik said the investigators were surprised to find the constellation of symptoms in their patients: eight children from two related families.

The symptoms of the new disease, CATIFA, can be explained by loss of collagen function, Knapik said. Collagen is the main structural component of the extracellular matrix -- the "mortar" between the cellular "bricks."

Using zebrafish, Knapik and her team were able to determine that the RIC1 protein is part of the cellular machinery that processes and ships collagen out of the cell.

"In the absence of RIC1, you don't get the collagen shipment, and you don't have matrix," Knapik said. "That leads to the broad spectrum of symptoms that we find in the electronic health records of adults and in the children with CATIFA."

The findings support the concept of a continuum between the individual symptoms in a rare, Mendelian disease -- a disease caused by mutation of a single gene -- and the complex traits of common diseases, Knapik said. Knowing the mechanistic underpinning for the disease and the symptoms that may arise will improve and personalize care for children with CATIFA and for adults with similar symptoms caused by less efficient activity of RIC1, Knapik added.

The study suggests a new paradigm for accelerating the discovery process for disease mechanisms, Knapik said.

"With knowledge coming from animal models, human common disease biobanks and rare Mendelian diseases, we can put together a complete picture of gene function and advance toward better diagnosis, treatment and prevention," she said.

VUMC researchers joining Knapik, Gamazon and Cox on the study are first author Gokhan Unlu, PhD, Amy Rushing, B. Eng, Xinzi Qi, David Melville, PhD; VU researchers are Rui Chen, PhD, Bingshan Li, PhD; clinical collaborators in Saudi Arabia include Fowzan S. Alkuraya, MD, Nisha Patel, PhD, Mais Hashem, MS, and Abdullah Al-Faifi, MD. The research was supported by the National Institutes of Health (grants MH113362, HG009086, HG010718, GM008554).

 
Share:

Related Articles:


Recent Articles

Study Shows ICU Patients with Low-Risk Penicillin Allergies Can Be Tested and Treated

Read More

Cummunity Comes Together Archives

Read More

AHA, AMA & ANA SEND JOINT LETTER TO CONGRESS ON CORONAVIRUS EMERGENCY FUNDING

Read More

Scope of Practice Update

Read More

AHIP Statement on Final CMS and ONC Interoper-ability Rules

Matt Eyles, president and CEO of America's Health Insurance Plans (AHIP), issued this statement following the Centers for Medicare & Medicaid Services' (CMS) final rule on Interoperability and Patient Access, and the Office of the National Coordinator (ONC) for Health Information Technology final rule on Interoperability, Information Blocking, and the ONC Health IT Certification Program:

Read More

Alexander Statement on Final Electronic Health Records Rules

U.S. Senate health committee Chairman Lamar Alexander (R-Tenn.) released the following statement after the Trump Administration released two final electronic health record rules:

Read More

A New Era in Nephrology

New therapies are beginning to come online to change outcomes for kidney disease patients.

Read More

Solving the Rural Health Puzzle

Hospital closures, alternative payment models, workforce issues and an older, sicker population have combined to create huge challenges in delivering rural care.

Read More

The Kidney Project: Pioneering Hope

The Kidney Project is bringing new hope to patients with end stage renal disease.

Read More

Saint Thomas, Nephrology Associates Partner on Transplant

Ascension Saint Thomas and Nephrology Associates recently announced an exclusive partnership to expand kidney transplant care.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: